Facts and myths about antibiotic therapy Review article
Article Sidebar
Main Article Content
Abstract
Resistance to antibiotics is becoming a serious clinical problem. It increases the cost of treatment and is the reason for the failure of therapy. It cannot be eliminated, but the principles of prevention must be respected. First, do not prescribe chemotherapeutics in the therapy of viral infections and symptomatic treatment, after the second care to the selection of a sufficiently high dose, recommend regular intake of the drug and do not shorten the time of therapy. It is also important to choose the right active substance, which should be conditioned by the expected sensitivity of bacteria, the localization of inflammation and the age of the patient. Do not forget about the accompanying therapy, including the ordination of the probiotic and antifungal protection.
Article Details
Copyright © by Medical Education. All rights reserved.
References
2. Todar K. Bacterial Resistance to Antibiotics. Lectures in Microbiology. 2009. http://www.mifami.org/eLibrary.
3. Björkman J, Nagaev I, Berg OG et al. Effects of Environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science. 2000; 2: 1479-82.
4. MilwardBrown SMG/KRC na zlecenie Narodowego Instytutu Leków. 2010.
5. Raport Narodowego Instytutu Leków. 2010.
6. Hryniewicz W, Mazińska B. Europejski Dzień Wiedzy o Antybiotykach – dlaczego potrzebny? Narodowy Instytut Leków w Warszawie, Zakład Epidemiologii i Mikrobiologii Klinicznej, Narodowy Program Ochrony Antybiotyków 2009. Pol Merkur Lekarski. 2009; 27: 261-4.
7. Mylonas I. Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration. Arch Gynecol Obstet. 2011; 283: 7-18.
8. Bookstaver BP, Bland CM, Griffin B et al. A Review of Antibiotic Use in Pregnancy. Pharmacotherapy. 2015; 35(11): 1052-62.
9. Pawlik K, Hryniewicz W. Antybiotykoterapia w położnictwie. Aktualności Narodowego Programu Ochrony Antybiotyków 2017; 3: 1-4.
10. Pichichero ME, Green JL, Marsocci SM et al. Recurrent group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 1998; 17: 809-15.